You are previewing Foods, Nutrients and Food Ingredients with Authorised EU Health Claims.
O'Reilly logo
Foods, Nutrients and Food Ingredients with Authorised EU Health Claims

Book Description

Foods, Nutrients and Food Ingredients with Authorised EU Health Claims provides an overview of how health claims are regulated in the EU as well as detailed scientific and regulatory information about permitted health claims for particular types of foods and ingredients.

Part one provides a background to the regulation of health claims in Europe. Part two focuses on authorised disease risk reduction claims, claims relating to children’s development and health and proprietary claims. Part three sets out ingredients with permitted ‘general function’ claims, including choline, creatine, sweeteners, dietary lactase supplements and polyphenols in olive oil. Part four outlines foods and nutrients with permitted health claims, with chapters on vitamins and minerals, proteins, meat, fish, water and the replacement of saturated fats.

Foods, Nutrients and Food Ingredients with Authorised EU Health Claims will be a standard reference for R&D managers and technical managers in the food, and beverage and dietary supplements industry, product development managers, health professionals and academic researchers in the field.



  • Provides a comprehensive overview of foods and food substances that have achieved approved health claims in Europe under Regulation EC 1924/2006
  • Covers properties and applications of each ingredient, as well as evidence for the health claim and how it benefits consumers
  • Outlines the importance of each claim in product development and marketing and regulatory issues such as conditions of use

Table of Contents

  1. Cover image
  2. Title page
  3. Copyright
  4. Contributor contact details
  5. Woodhead Publishing Series in Food Science, Technology and Nutrition
  6. Foreword
  7. References
  8. Preface
  9. Part I: Regulatory background
    1. 1. The regulation of health claims in Europe
      1. Abstract:
      2. 1.1 Introduction
      3. 1.2 Definitions
      4. 1.3 Development of the list of claims under Article 13.3
      5. 1.4 Regulatory approval procedure for Article 13.5 and 14 health claims
      6. 1.5 Transition periods
      7. 1.6 Scientific substantiation
      8. 1.7 Community Register of claims
      9. 1.8 Wording of health claims
      10. 1.9 Labelling
      11. 1.10 Nutrient profiling
      12. 1.11 Conclusion and future trends
      13. 1.12 Sources of further information and advice
      14. 1.13 References
  10. Part II: Authorised disease risk reduction claims, children’s development and health claims, and proprietary claims
    1. 2. Authorised EU health claims for barley and oat beta-glucans
      1. Abstract:
      2. 2.1 Introduction
      3. 2.2 Authorised Article 13.1/14.1(a) cholesterol claims
      4. 2.3 Summary of substantiating evidence related to cholesterol claims
      5. 2.4 Other relevant legislation
      6. 2.5 Conditions of use, warning labels and safety issues
      7. 2.6 Consumer issues
      8. 2.7 How the claims are being used in practice
      9. 2.8 Future trends
      10. 2.9 Conclusion
      11. 2.10 Sources of further information and advice
      12. 2.11 References
    2. 3. Authorised EU health claims for xylitol and sugar-free chewing gum (SFCG)
      1. Abstract:
      2. 3.1 Introduction
      3. 3.2 The chemical profile of xylitol
      4. 3.3 Authorised health claims
      5. 3.4 Substantiating evidence
      6. 3.5 Other relevant legislation
      7. 3.6 Warning labels and safety issues
      8. 3.7 Incorporation of sugar-free chewing gum (SFCG) as part of a balanced dietary regimen
      9. 3.8 Consumer understanding of the wording used in recommendations
      10. 3.9 Use of dental health claims in practice
      11. 3.10 Medical and other uses of xylitol chewing gum
      12. 3.11 Future trends
      13. 3.12 Conclusion
      14. 3.13.References
    3. 4. Authorised children’s development and health claims in the EU
      1. Abstract:
      2. 4.1 Introduction
      3. 4.2 Authorised health claims
      4. 4.3 Summary of substantiating evidence
      5. 4.4 Other relevant legislation
      6. 4.5 Conditions of use, warning labels and safety issues
      7. 4.6 Consumer issues
      8. 4.7 How the claims are being used in practice
      9. 4.8 Future trends
      10. 4.9 Conclusion
      11. 4.10 Sources of further information and advice
      12. 4.11 References
    4. 5. Authorised EU health claims for water-soluble tomato concentrate (WSTC)
      1. Abstract:
      2. 5.1 Introduction
      3. 5.2 Epidemiology of tomato consumption and <strong xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops">cardiovascular disease</strong> ( (<strong xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops">CVD</strong>) ) <strong xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops">risk</strong>
      4. 5.3 Human platelets and vascular homeostasis
      5. 5.4 Isolation and characterisation of water-soluble tomato <strong xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops">extract</strong>: : <strong xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops">effects on human platelet aggregation</strong>
      6. 5.5 Further characterisation of water-soluble tomato extract
      7. 5.6 Human trials using the water-soluble tomato extract
      8. 5.7 EU approval of the health claim of the platelet inhibitory property of the water-soluble tomato extract
      9. 5.8 Commercially available Fruitflow® products
      10. 5.9 Conclusion
      11. 5.10 Acknowledgement
      12. 5.11 References.
  11. Part III: Ingredients with permitted ‘general function’ claims
    1. 6. Authorised EU health claims for choline
      1. Abstract:
      2. 6.1 Introduction
      3. 6.2 Characterization of the substance
      4. 6.3 Allowable health claims according to Commission Regulation 423/2012
      5. 6.4 Other relevant EU legislation
      6. 6.5 Conditions of use and safety considerations
      7. 6.6 Consumer issues
      8. 6.7 Potential of health claims in product development
      9. 6.8 Claims being used in practice
      10. 6.9 Conclusion and future trends
      11. 6.11 Acknowledgements
      12. 6.10 Sources of further information and advice
      13. 6.12 References
    2. 7. Authorised EU health claims for creatine
      1. Abstract:
      2. 7.1 Introduction
      3. 7.2 Creatine characterisation
      4. 7.3 Authorised health claim
      5. 7.4 Legislation relevant to the use of the creatine health claim
      6. 7.5 Consumer issues
      7. 7.6 Importance of the claim in product development
      8. 7.7 Future trends
      9. 7.8 Conclusion
      10. 7.9 References
    3. 8. Authorised EU health claims for intense sweeteners and sugar replacers
      1. Abstract:
      2. 8.1 Introduction
      3. 8.2 Overview of intense sweeteners and sugar replacers
      4. 8.3 Applications of intense sweeteners and sugar replacers, related authorised nutrition and health claims
      5. 8.4 Safety of intense sweeteners and sugar replacers
      6. 8.5 Conclusion and future trends
      7. 8.6 Sources of further information and advice
      8. 8.7 References
    4. 9. Authorised EU health claims related to the management of lactose intolerance: reduced lactose content, dietary lactase supplements and live yoghurt cultures
      1. Abstract:
      2. 9.1 Introduction
      3. 9.2 Lactose maldigestion and intolerance
      4. 9.3 Foods with reduced lactose content
      5. 9.4 Lactase enzyme, as a dietary supplement
      6. 9.5 Live yoghurt cultures
      7. 9.6 Conclusion and future trends
      8. 9.7 References
    5. 10. Authorised EU health claims for polyphenols in olive oil
      1. Abstract:
      2. 10.1 Introduction
      3. 10.2 Characterisation of polyphenols in olive products
      4. 10.3 Authorised health claim
      5. 10.4 Role of low density lipoprotein (LDL) oxidation in cardiovascular disease (CVD) risk
      6. 10.5 Studies that supported the claim
      7. 10.6 Mechanism of oxLDL reduction by intake of olive oil phenolics
      8. 10.7 Unsuccessful health claims
      9. 10.8 Safety issues and conditions of use
      10. 10.9 Consumer issues
      11. 10.10 How the claim is being used in practice
      12. 10.11 Conclusion and future trends
      13. 10.12 References.
    6. 11. Authorised EU health claims for resistant starch and post-prandial glycaemic responses
      1. Abstract:
      2. 11.1 Introduction
      3. 11.2 Characterisation of the ingredient
      4. 11.3 Authorised health claim
      5. 11.4 Summary of substantiating evidence
      6. 11.5 Nutrition labelling and nutrition claims regulations
      7. 11.6 Conditions of use
      8. 11.7 Consumer issues
      9. 11.8 Future trends
      10. 11.9 Conclusion
      11. 11.10 Sources of further information and advice
      12. 11.11 References
  12. Part IV: Foods and nutrients with permitted health claims
    1. 12. Authorised EU health claims for betaine
      1. Abstract:
      2. 12.1 Introduction
      3. 12.2 Characterisation of betaine
      4. 12.3 Authorised health claim on normal homocysteine metabolism
      5. 12.4 Interaction with other EU legislation concerning betaine
      6. 12.5 Conditions of use of betaine
      7. 12.6 Consumer understanding
      8. 12.7 Importance of the claim in food product development and supplement marketing
      9. 12.8 Future trends
      10. 12.9 Conclusion
      11. 12.10 Sources of further information
      12. 12.11 References
    2. 13. Authorised EU health claims for vitamins and minerals
      1. Abstract:
      2. 13.1 Introduction
      3. 13.2 Characterisation
      4. 13.3 Authorised claims for vitamins and minerals
      5. 13.4 Conditions of use
      6. 13.5 Consumer issues
      7. 13.6 Other relevant legislation
      8. 13.7 Importance of the claim in product development and potential future trends
      9. 13.8 Conclusion
      10. 13.9 Sources of further information and advice
      11. 13.10 References
    3. 14. Authorised EU health claims for the replacement of saturated fats
      1. Abstract:
      2. 14.1 Introduction
      3. 14.2 Characterisation of the constituents
      4. 14.3 Scientific substantiation for the authorised claim: fatty acids (FA) and cholesterol
      5. 14.4 Dietary recommendations and further considerations
      6. 14.5 Impact on product development
      7. 14.6 Consumer issues
      8. 14.7 Future trends
      9. 14.8 Sources of further information and advice
      10. 14.9 References
    4. 15. Authorised EU health claims for proteins, meat and fish
      1. Abstract:
      2. 15.1 Introduction
      3. 15.2 Nutrition labelling
      4. 15.3 Nutrient claims
      5. 15.4 Health claims
      6. 15.5 Consumer aspects
      7. 15.6 Conclusion
      8. 15.7 References
    5. 16. Authorised EU health claim for walnuts
      1. Abstract:
      2. 16.1 Introduction
      3. 16.2 Characterisation of walnuts
      4. 16.3 Health claims related to walnuts in the EU
      5. 16.4 Health claims related to walnuts in other jurisdictions
      6. 16.5 Health claims related to other nuts in the EU and various jurisdictions
      7. 16.6 Conclusion
      8. 16.7 References
    6. 17. Authorised EU health claims for carbohydrate-electrolyte solutions
      1. Abstract:
      2. 17.1 Introduction
      3. 17.2 Characteristics of carbohydrate-electrolyte solutions
      4. 17.3 Health claim evaluation
      5. 17.4 Benefits to consumers and use of sports drinks
      6. 17.5 Scientific substantiation of efficacy
      7. 17.6 Product development issues
      8. 17.7 Claim usage
      9. 17.8 Future trends
      10. 17.9 Conclusion
      11. 17.10 Sources of further information and advice
      12. 17.11 References
    7. 18. Authorised EU health claims for water
      1. Abstract:
      2. 18.1 Introduction
      3. 18.2 Authorised health claims
      4. 18.3 Substantiating evidence
      5. 18.4 Further guidance
      6. 18.5 Consumer issues
      7. 18.6 Importance or potential of the claim in product development
      8. 18.7 Future trends
      9. 18.8 Conclusion
      10. 18.9 Acknowledgement
      11. 18.10 Sources of further information and advice
      12. 18.11 References
  13. Index